Alexion Pharmaceuticals Analysts Recommendations and Consensus

ALXN -- USA Stock  

USD 121.99  2.62  2.10%

The current analyst and expert consensus on Alexion Pharmaceuticals is Buy with 7 hold recommendations. The current projected target price consensus is 160.5 with 16 analysts opinions. One of the most common ways Alexion Pharmaceuticals analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Alexion Pharmaceuticals vendors, executives, and/or customers. Alexion Pharmaceuticals recommendation module provides expert sentiment on the projected Alexion Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 24.314. Check also Macroaxis Advice on Alexion Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Alexion Pharmaceuticals Target Price Consensus

Number of Opinions21
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Alexion Pharmaceuticals Target Price Projection

Current Price

Alexion Pharmaceuticals Market Quote

Low Price121.91Odds
High Price125.5Odds

121.99

Target Price

Analyst Consensus On Target Price

Low Estimate120.0Odds
High Estimate217.0Odds
Number of Analysts16
Standard Deviation24.314

160.5

Alexion Pharmaceuticals Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Artificial Intelligence
Purchased a lot of shares
Traded a day ago for 156.0
Artificial Intelligence
Purchased a lot of shares
Traded a day ago for 156.0
Driverless Cars
Purchased over 300 shares
Traded a day ago for 9.81
Baby Boomer Prospects
Purchased over 40 shares
Traded a day ago for 74.735
Driverless Cars
Purchased over 70 shares
Traded a day ago for 36.08
Momentum
Purchased a lot of shares
Traded a day ago for 153.4
Check also Macroaxis Advice on Alexion Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.
Search macroaxis.com